Global Sterile Injectables Market – Analysis By Molecule Type, Drug Type, Indication, Distribution Channel, By Region, By Country (2018 Edition): Forecast to 2023 - Molecule Type (Biologic, Small Molecule), Drug Type (Monoclonal Antibody, Insulin, Vaccine, Fusion Protein, Immunoglobulin), Indication (Disorders – Oncological, Cardiovascular, Neurological, Infectious, Metabolic, Musculoskeletal), Channel (Hospital Pharmacy, Retail Pharmacy, E-commerce)
EXECUTIVE SUMMARY
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Sterile Injectables Market by Molecule Type (Biologic, Small Molecule), Drug Type (Monoclonal Antibody, Insulin, Vaccine, Fusion Protein, Immunoglobulin), Indication (Disorders – Oncological, Cardiovascular, Neurological, Infectious, Metabolic, Musculoskeletal), Channel (Hospital Pharmacy, Retail Pharmacy, E-commerce). The report assess the global market, the regional markets (APAC, North America, Europe, ROW) and country analysis (United States, Canada, United Kingdom, Germany, China, India, Japan, Brazil, Saudi Arabia).
According to Azoth Analytics research report “Global Sterile Injectables Market – Analysis By Molecule Type, Drug Type, Indication, Distribution Channel, By Region, By Country (2018 Edition): Forecast to 2023 - Molecule Type (Biologic, Small Molecule), Drug Type (Monoclonal Antibody, Insulin, Vaccine, Fusion Protein, Immunoglobulin), Indication (Disorders – Oncological, Cardiovascular, Neurological, Infectious, Metabolic, Musculoskeletal), Channel (Hospital Pharmacy, Retail Pharmacy, E-commerce)” the global market is projected to display a robust growth represented by a CAGR of 6.39 % during 2018 – 2023.
Growth of the global sterile injectables market is primarily driven by increasing prevalence of chronic diseases and rapidly increasing ageing population that are highly susceptible to chronic diseases. Moreover, rise in the global healthcare expenditure, changing lifestyle and rising demand for the better quality of life are some of the macro economic factors which impelled the growth of the market.
The report titled “Global Sterile Injectables Market – Analysis By Molecule Type, Drug Type, Indication, Distribution Channel, By Region, By Country (2018 Edition): Forecast to 2023 - Molecule Type (Biologic, Small Molecule), Drug Type (Monoclonal Antibody, Insulin, Vaccine, Fusion Protein, Immunoglobulin), Indication (Disorders – Oncological, Cardiovascular, Neurological, Infectious, Metabolic, Musculoskeletal), Channel (Hospital Pharmacy, Retail Pharmacy, E-commerce)” has covered and analysed the potential of Global Sterile Injectables Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global sterile injectables. Additionally, the report also highlights market entry dynamics for various companies across the globe.
SCOPE OF THE REPORT
Global Market (Actual Period: 2013-2017, Forecast Period: 2018-2023)
The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Sterile Injectables Market by Molecule Type (Biologic, Small Molecule), Drug Type (Monoclonal Antibody, Insulin, Vaccine, Fusion Protein, Immunoglobulin), Indication (Disorders – Oncological, Cardiovascular, Neurological, Infectious, Metabolic, Musculoskeletal), Channel (Hospital Pharmacy, Retail Pharmacy, E-commerce). The report assess the global market, the regional markets (APAC, North America, Europe, ROW) and country analysis (United States, Canada, United Kingdom, Germany, China, India, Japan, Brazil, Saudi Arabia).
According to Azoth Analytics research report “Global Sterile Injectables Market – Analysis By Molecule Type, Drug Type, Indication, Distribution Channel, By Region, By Country (2018 Edition): Forecast to 2023 - Molecule Type (Biologic, Small Molecule), Drug Type (Monoclonal Antibody, Insulin, Vaccine, Fusion Protein, Immunoglobulin), Indication (Disorders – Oncological, Cardiovascular, Neurological, Infectious, Metabolic, Musculoskeletal), Channel (Hospital Pharmacy, Retail Pharmacy, E-commerce)” the global market is projected to display a robust growth represented by a CAGR of 6.39 % during 2018 – 2023.
Growth of the global sterile injectables market is primarily driven by increasing prevalence of chronic diseases and rapidly increasing ageing population that are highly susceptible to chronic diseases. Moreover, rise in the global healthcare expenditure, changing lifestyle and rising demand for the better quality of life are some of the macro economic factors which impelled the growth of the market.
The report titled “Global Sterile Injectables Market – Analysis By Molecule Type, Drug Type, Indication, Distribution Channel, By Region, By Country (2018 Edition): Forecast to 2023 - Molecule Type (Biologic, Small Molecule), Drug Type (Monoclonal Antibody, Insulin, Vaccine, Fusion Protein, Immunoglobulin), Indication (Disorders – Oncological, Cardiovascular, Neurological, Infectious, Metabolic, Musculoskeletal), Channel (Hospital Pharmacy, Retail Pharmacy, E-commerce)” has covered and analysed the potential of Global Sterile Injectables Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global sterile injectables. Additionally, the report also highlights market entry dynamics for various companies across the globe.
SCOPE OF THE REPORT
Global Market (Actual Period: 2013-2017, Forecast Period: 2018-2023)
- Sterile Injectables Market – Sizing, Growth, Forecast
- Molecule Type - Biologic, Small Molecule
- Drug Type - Monoclonal Antibody, Insulin, Vaccine, Fusion Protein, Immunoglobulin
- Indication (Oncological Disorders, Cardiovascular Disorders, Neurological Disorders, Infectious Disorders, Metabolic Disorders, Musculoskeletal Disorders)
- Distribution Channel (Hospital Pharmacy, Retail Pharmacy, E-commerce)
- Sterile Injectables Market – Sizing, Growth, Forecast
- Molecule Type - Biologic, Small Molecule
- Drug Type - Monoclonal Antibody, Insulin, Vaccine, Fusion Protein, Immunoglobulin
- Indication (Oncological Disorders, Cardiovascular Disorders, Neurological Disorders, Infectious Disorders, Metabolic Disorders, Musculoskeletal Disorders)
- Distribution Channel (Hospital Pharmacy, Retail Pharmacy, E-commerce)
- Sterile Injectables Market – Sizing, Growth, Forecast
- Molecule Type - Biologic, Small Molecule
- Drug Type - Monoclonal Antibody, Insulin, Vaccine, Fusion Protein, Immunoglobulin
- Indication (Oncological Disorders, Cardiovascular Disorders, Neurological Disorders, Infectious Disorders, Metabolic Disorders, Musculoskeletal Disorders)
- Distribution Channel (Hospital Pharmacy, Retail Pharmacy, E-commerce)
- Market Dynamics – Drivers and Restraints
- Market Trends
- Porter Five Force Analysis
- Policy and Regulatory Landscape
- Company Analysis – Sanofi, Pfizer, Baxer International, Glaxo smith kline, Novartis, Gilead Sciences, Merck & Co., Astra Zeneca
The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.
1. RESEARCH METHODOLOGY
2. EXECUTIVE SUMMARY
3. STRATEGIC RECOMMENDATIONS
4 STERILE INJECTABLES OUTLOOK
5 GLOBAL STERILE INJECTABLES: GROWTH AND FORECAST
5.1 By Value (2013-2017)
5.2 By Value (2018-2023)
6. GLOBAL STERILE INJECTABLES MARKET – SEGMENT ANALYSIS
6.1 Global Sterile Injectables Market – By Molecule Type
6.1.1 By Type, 2017 (%)
6.1.2 By Type, 2023 (%)
6.2 Global Biologic Sterile Injectables Market, By Value (2013-2023)
6.3 Global Small Molecule Sterile Injectables Market, By Value (2013-2023)
6.4 Global Sterile Injectables Market – By Biologic Drug Type
6.4.1 By Type, 2017 (%)
6.4.2 By Type, 2023 (%)
6.5 Global Monoclonal Antibody Sterile Injectables Market, By Value (2013-2023)
6.6 Global Insulin Sterile Injectables Market, By Value (2013-2023)
6.7 Global Vaccines Sterile Injectables Market, By Value (2013-2023)
6.8 Global Fusion Proteins Sterile Injectables Market, By Value (2013-2023)
6.9 Global Immunoglobulins Sterile Injectables Market, By Value (2013-2023)
6.10 Global Others Biologic Sterile Injectables Market, By Value (2013-2023)
6.11 Global Sterile Injectables Market – By Indication
6.11.1 By Indication, 2017 (%)
6.11.2 By Indication, 2023 (%)
6.12 Global Sterile Injectables For Oncological Disorders Market, By Value (2013-2023)
6.13 Global Sterile Injectables For Infectious Disorders Market, By Value (2013-2023)
6.14 Global Sterile Injectables For Metabolic Disorders Market, By Value (2013-2023)
6.15 Global Sterile Injectables For Cardiovascular Disorders Market, By Value (2013-2023)
6.16 Global Sterile Injectables For Neurological Disorders Market, By Value (2013-2023)
6.17 Global Sterile Injectables For Musculoskeletal Disorders Market, By Value (2013-2023)
6.18 Global Others Indication Sterile Injectables Market, By Value (2013-2023)
6.19 Global Sterile Injectables Market – By Distribution Channel
6.19.1 By Distribution Channel, By Value, 2017 (%)
6.19.2 By Distribution Channel, By Value, 2023 (%)
6.20 Global Hospital Pharmacy Sterile Injectables Market, By Value (2013-2023)
6.21 Global Retail Pharmacy Sterile Injectables Market, By Value (2013-2023)
6.22 Global Ecommerce Sterile Injectables Market, By Value (2013-2023)
7. GLOBAL STERILE INJECTABLES MARKET: REGIONAL ANALYSIS
7.1 Global Sterile Injectables Market Size, By Region: Breakdown (%)
7.1.1 By Region, By Value, 2017 (%)
7.1.2 By Region, By Value, 2023 (%)
7.2 North America Sterile Injectables Market: An Analysis
7.2.1 By Value (2013-2017)
7.2.2 By Value (2018-2023)
7.2.3 By Molecule Type, By Value (2013-2023)
7.2.4 By Biologic Drug Type, By Value (2013-2023)
7.2.5 By Indication, By Value (2013-2023)
7.2.6 By Distribution Channel, By Value (2013-2023)
7.3 North America Sterile Injectables Market, Country Share Analysis: 2017(%) and 2023F (%)
7.3.1 U.S Sterile Injectables Market, By Value (2013-2023)
7.3.2 U.S Sterile Injectables Market, By Indication, By Value (2013-2023)
7.3.3 Canada Sterile Injectables Market, By Value (2013-2023)
7.3.4 Canada Sterile Injectables Market, By Indication, By Value (2013-2023)
7.4 Europe Sterile Injectables Market: An Analysis
7.4.1 By Value (2013-2017)
7.4.2 By Value (2018-2023)
7.4.3 By Molecule Type, By Value (2013-2023)
7.4.4 By Biologic Drug Type, By Value (2013-2023)
7.4.5 By Indication, By Value (2013-2023)
7.4.6 By Distribution Channel, By Value (2013-2023)
7.5 Europe Sterile Injectables Market, Country Share Analysis: 2017(%) and 2023F (%)
7.5.1 Germany Sterile Injectables Market, By Value (2013-2023)
7.5.2 Germany Sterile Injectables Market, By Indication, By Value (2013-2023)
7.5.3 United Kingdom Sterile Injectables Market, By Value (2013-2023)
7.5.4 United Kingdom Injectables Market, By Indication, By Value (2013-2023)
7.5.5 Rest of Europe Sterile Injectables Market, By Value (2013-2023)
7.7 APAC Sterile Injectables Market: An Analysis
7.7.1 By Value (2013-2017)
7.7.2 By Value (2018-2023)
7.7.3 By Molecule Type, By Value (2013-2023)
7.7.4 By Biologic Drug Type, By Value (2013-2023)
7.7.5 By Indication, By Value (2013-2023)
7.7.6 By Distribution Channel, By Value (2013-2023)
7.8 APAC Sterile Injectables Market, Country Share Analysis: 2017(%) and 2023F (%)
7.8.1 China Sterile Injectables Market, By Value (2013-2023)
7.8.2 China Sterile Injectables Market, By Indication, By Value (2013-2023)
7.8.3 Japan Sterile Injectables Market, By Value (2013-2023)
7.8.4 Japan Injectables Market, By Indication, By Value (2013-2023)
7.8.5 India Sterile Injectables Market, By Value (2013-2023)
7.8.6 India Injectables Market, By Indication, By Value (2013-2023)
7.8.7 Rest of APAC Sterile Injectables Market, By Value (2013-2023)
7.9 Rest of the World Sterile Injectables Market: An Analysis
7.9.1 By Value (2013-2017)
7.9.2 By Value (2018-2023)
7.9.3 By Molecule Type, By Value (2013-2023)
7.9.4 By Biologic Drug Type, By Value (2013-2023)
7.9.5 By Distribution Channel, By Value (2013-2023)
7.10 Rest of the World Sterile Injectables Market, Country Share Analysis: 2017(%) and 2023F (%)
7.5.1 Brazil Sterile Injectables Market, By Value (2013-2023)
7.5.2 Brazil Sterile Injectables Market, By Indication, By Value (2013-2023)
7.5.3 Saudi Arabia Sterile Injectables Market, By Value (2013-2023)
7.5.4 Saudi Arabia Injectables Market, By Indication, By Value (2013-2023)
7.5.5 Other Sterile Injectables Market, By Value (2013-2023)
8. GLOBAL STERILE INJECTABLES MARKET DYNAMICS
8.1 Global Sterile Injectables Market Drivers
8.2 Global Sterile Injectables Market Restraints
9. GLOBAL STERILE INJECTABLES MARKET TRENDS
10. POLICY AND REGULATORY LANDSCAPE
11. PORTER FIVE FORCE ANALYSIS
12. SWOT ANALYSIS
13. COMPANY PROFILES
13.1 Sanofi
13.2 Pfizer
13.3 Baxer International
13.4 Glaxosmithkline
13.5 Novartis
13.6 Gilead Sciences
13.7 Merck & Co.
13.8 Astra Zeneca
2. EXECUTIVE SUMMARY
3. STRATEGIC RECOMMENDATIONS
4 STERILE INJECTABLES OUTLOOK
5 GLOBAL STERILE INJECTABLES: GROWTH AND FORECAST
5.1 By Value (2013-2017)
5.2 By Value (2018-2023)
6. GLOBAL STERILE INJECTABLES MARKET – SEGMENT ANALYSIS
6.1 Global Sterile Injectables Market – By Molecule Type
6.1.1 By Type, 2017 (%)
6.1.2 By Type, 2023 (%)
6.2 Global Biologic Sterile Injectables Market, By Value (2013-2023)
6.3 Global Small Molecule Sterile Injectables Market, By Value (2013-2023)
6.4 Global Sterile Injectables Market – By Biologic Drug Type
6.4.1 By Type, 2017 (%)
6.4.2 By Type, 2023 (%)
6.5 Global Monoclonal Antibody Sterile Injectables Market, By Value (2013-2023)
6.6 Global Insulin Sterile Injectables Market, By Value (2013-2023)
6.7 Global Vaccines Sterile Injectables Market, By Value (2013-2023)
6.8 Global Fusion Proteins Sterile Injectables Market, By Value (2013-2023)
6.9 Global Immunoglobulins Sterile Injectables Market, By Value (2013-2023)
6.10 Global Others Biologic Sterile Injectables Market, By Value (2013-2023)
6.11 Global Sterile Injectables Market – By Indication
6.11.1 By Indication, 2017 (%)
6.11.2 By Indication, 2023 (%)
6.12 Global Sterile Injectables For Oncological Disorders Market, By Value (2013-2023)
6.13 Global Sterile Injectables For Infectious Disorders Market, By Value (2013-2023)
6.14 Global Sterile Injectables For Metabolic Disorders Market, By Value (2013-2023)
6.15 Global Sterile Injectables For Cardiovascular Disorders Market, By Value (2013-2023)
6.16 Global Sterile Injectables For Neurological Disorders Market, By Value (2013-2023)
6.17 Global Sterile Injectables For Musculoskeletal Disorders Market, By Value (2013-2023)
6.18 Global Others Indication Sterile Injectables Market, By Value (2013-2023)
6.19 Global Sterile Injectables Market – By Distribution Channel
6.19.1 By Distribution Channel, By Value, 2017 (%)
6.19.2 By Distribution Channel, By Value, 2023 (%)
6.20 Global Hospital Pharmacy Sterile Injectables Market, By Value (2013-2023)
6.21 Global Retail Pharmacy Sterile Injectables Market, By Value (2013-2023)
6.22 Global Ecommerce Sterile Injectables Market, By Value (2013-2023)
7. GLOBAL STERILE INJECTABLES MARKET: REGIONAL ANALYSIS
7.1 Global Sterile Injectables Market Size, By Region: Breakdown (%)
7.1.1 By Region, By Value, 2017 (%)
7.1.2 By Region, By Value, 2023 (%)
7.2 North America Sterile Injectables Market: An Analysis
7.2.1 By Value (2013-2017)
7.2.2 By Value (2018-2023)
7.2.3 By Molecule Type, By Value (2013-2023)
7.2.4 By Biologic Drug Type, By Value (2013-2023)
7.2.5 By Indication, By Value (2013-2023)
7.2.6 By Distribution Channel, By Value (2013-2023)
7.3 North America Sterile Injectables Market, Country Share Analysis: 2017(%) and 2023F (%)
7.3.1 U.S Sterile Injectables Market, By Value (2013-2023)
7.3.2 U.S Sterile Injectables Market, By Indication, By Value (2013-2023)
7.3.3 Canada Sterile Injectables Market, By Value (2013-2023)
7.3.4 Canada Sterile Injectables Market, By Indication, By Value (2013-2023)
7.4 Europe Sterile Injectables Market: An Analysis
7.4.1 By Value (2013-2017)
7.4.2 By Value (2018-2023)
7.4.3 By Molecule Type, By Value (2013-2023)
7.4.4 By Biologic Drug Type, By Value (2013-2023)
7.4.5 By Indication, By Value (2013-2023)
7.4.6 By Distribution Channel, By Value (2013-2023)
7.5 Europe Sterile Injectables Market, Country Share Analysis: 2017(%) and 2023F (%)
7.5.1 Germany Sterile Injectables Market, By Value (2013-2023)
7.5.2 Germany Sterile Injectables Market, By Indication, By Value (2013-2023)
7.5.3 United Kingdom Sterile Injectables Market, By Value (2013-2023)
7.5.4 United Kingdom Injectables Market, By Indication, By Value (2013-2023)
7.5.5 Rest of Europe Sterile Injectables Market, By Value (2013-2023)
7.7 APAC Sterile Injectables Market: An Analysis
7.7.1 By Value (2013-2017)
7.7.2 By Value (2018-2023)
7.7.3 By Molecule Type, By Value (2013-2023)
7.7.4 By Biologic Drug Type, By Value (2013-2023)
7.7.5 By Indication, By Value (2013-2023)
7.7.6 By Distribution Channel, By Value (2013-2023)
7.8 APAC Sterile Injectables Market, Country Share Analysis: 2017(%) and 2023F (%)
7.8.1 China Sterile Injectables Market, By Value (2013-2023)
7.8.2 China Sterile Injectables Market, By Indication, By Value (2013-2023)
7.8.3 Japan Sterile Injectables Market, By Value (2013-2023)
7.8.4 Japan Injectables Market, By Indication, By Value (2013-2023)
7.8.5 India Sterile Injectables Market, By Value (2013-2023)
7.8.6 India Injectables Market, By Indication, By Value (2013-2023)
7.8.7 Rest of APAC Sterile Injectables Market, By Value (2013-2023)
7.9 Rest of the World Sterile Injectables Market: An Analysis
7.9.1 By Value (2013-2017)
7.9.2 By Value (2018-2023)
7.9.3 By Molecule Type, By Value (2013-2023)
7.9.4 By Biologic Drug Type, By Value (2013-2023)
7.9.5 By Distribution Channel, By Value (2013-2023)
7.10 Rest of the World Sterile Injectables Market, Country Share Analysis: 2017(%) and 2023F (%)
7.5.1 Brazil Sterile Injectables Market, By Value (2013-2023)
7.5.2 Brazil Sterile Injectables Market, By Indication, By Value (2013-2023)
7.5.3 Saudi Arabia Sterile Injectables Market, By Value (2013-2023)
7.5.4 Saudi Arabia Injectables Market, By Indication, By Value (2013-2023)
7.5.5 Other Sterile Injectables Market, By Value (2013-2023)
8. GLOBAL STERILE INJECTABLES MARKET DYNAMICS
8.1 Global Sterile Injectables Market Drivers
8.2 Global Sterile Injectables Market Restraints
9. GLOBAL STERILE INJECTABLES MARKET TRENDS
10. POLICY AND REGULATORY LANDSCAPE
11. PORTER FIVE FORCE ANALYSIS
12. SWOT ANALYSIS
13. COMPANY PROFILES
13.1 Sanofi
13.2 Pfizer
13.3 Baxer International
13.4 Glaxosmithkline
13.5 Novartis
13.6 Gilead Sciences
13.7 Merck & Co.
13.8 Astra Zeneca
LIST OF FIGURES
Figure 1: Sterile Injectables Market By Type
Figure 2: Global Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 3: Global Sterile Injectables Market Size, By Value, Forecast, 2018-2023 (USD Billion)
Figure 4: Global Health Expenditure Per Capita,(2012-2016, USD Trillion)
Figure 5: Global Health Expenditure Per Capita, By Select Countries,(2016, USD)
Figure 6: Global Population Aged 65 and Above, 2012-2015 (% of Total)
Figure 7: Global Diabetic Population, By Region, 2015 (Billion)
Figure 8: Global Sterile Injectables Market Size, By Molecule Type, 2017 (%)
Figure 9: Global Sterile Injectables Market Size, By Molecule Type, 2023F (%)
Figure 10: Global Biologic Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 11: Global Biologic Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion)
Figure 12: Global Small Molecule Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 13: Global Small Molecule Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion)
Figure 14: Global Sterile Injectables Market Size, By Type, 2017 (%)
Figure 15: Global Therapeutic and Monitoring Devices Market Size, By Type, 2023F (%)
Figure 16: Global Monoclonal Antibody Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 17: Global Monoclonal Antibody Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion)
Figure 18: Global Insulin Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 19: Global Insulin Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion)
Figure 20: Top 10 Leading countries with diabetes Prevalence, Million, 2017
Figure 21: Highest Revenue Generating Insulin Drugs in 2016 & 2017
Figure 22: Global Vaccines Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 23: Global Vaccines Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion)
Figure 24: Market Share of Leading Vaccines Manufacturers
Figure 25: Global Vaccine Doses Consumption, By Income Group (Million,2016)
Figure 26: Global Fusion Proteins Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 27: Global Fusion Proteins Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion)
Figure 28: Global Immunoglobulins Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 29: Global Immunoglobulins Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion)
Figure 30: Global Others Biologic Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 31: Global Others Biologic Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion)
Figure 32: Global Sterile Injectables Market Size, By Indication, 2017 (%)
Figure 33: Global Sterile Injectables Market Size, By Indication, 2023F (%)
Figure 34: Global Sterile Injectables For Oncological Disorders Market Size, By Value, 2013-2017 (USD Billion)
Figure 35: Global Sterile Injectables For Oncological Disorders Market Size, By Value 2018E-2023F (USD Billion)
Figure 36: Number of People With Cancer, By Type, 2016 (Million)
Figure 37: Global Sterile Injectables For Infectious Disorders Market Size, By Value, 2013-2017 (USD Billion)
Figure 38: Global Sterile Injectables For Infectious Disorders Market Size, By Value 2018E-2023F (USD Billion)
Figure 39: Global Prevalence of Different Type of Infectious Disorders (2016,%)
Figure 40: Global Prevalence of Infectious Disorders (2012-2016, Million)
Figure 41: Global Prevalence of Neglected Tropical Disorders in (2012-2016, Million)
Figure 42: Global Prevalence of Neglected Tropical Disorders, By Type (2016,%)
Figure 43: Global Sterile Injectables For Metabolic Disorders Market Size, By Value, 2013-2017 (USD Billion)
Figure 44: Global Sterile Injectables For Metabolic Disorders Market Size, By Value 2018E-2023F (USD Billion)
Figure 45: Global Diabetes Prevalence (2017&2045, Million)
Figure 46: Global Sterile Injectables For Cardiovascular Disorders Market Size, By Value, 2013-2017 (USD Billion)
Figure 47: Global Sterile Injectables For Cardiovascular Disorders Size, By Value 2018E-2023F (USD Billion)
Figure 48: Cardiovascular Disease Prevelance, By Type,2016
Figure 49: Global Prevalence of Cardiovascular Disease (2012-2016, Million)
Figure 50: Global Sterile Injectables For Neurological Disorders Market Size, By Value, 2013-2017 (USD Billion)
Figure 51: Global Sterile Injectables For Neurological Disorders Market Size, By Value 2018E-2023F (USD Billion)
Figure 52: Neurological Disorders Prevalence, By Type,2016
Figure 53: Global Prevalence of Neurological Disorders (2012-2016, Billion)
Figure 54: Global Sterile Injectables For Musculoskeletal Disorders Market Size, By Value, 2013-2017 (USD Billion)
Figure 55: Global Sterile Injectables For Musculoskeletal Disorders Market Size, By Value 2018E-23F (USD Billion)
Figure 56: Musculoskeletal Disorders Prevalence, By Type, 2016
Figure 57: Global Prevalence of Musculoskeletal Disorders (2012-2016, Billion)
Figure 58: Global Others Indication Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 59: Global Others Indication Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion)
Figure 60: Global Prevalence of Gynecological Disorder (2012-2016, Million)
Figure 61: Global Prevalence of Gynecological Disorder, By Type 2016
Figure 62: Global Prevalence of Sense Organ Disorder (2012-2016, Million)
Figure 63: Global Sterile Injectables Market Size, By Distribution Channel, 2017 (%)
Figure 64: Global Sterile Injectables Market Size, By Distribution Channel, 2023F (%)
Figure 65: Global Hospital Pharmacy Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 66: Global Hospital Pharmacy Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion)
Figure 67: Global Retail Pharmacy Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 68: Global Retail Pharmacy Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion)
Figure 69: Global Ecommerce Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 70: Global Ecommerce Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion)
Figure 71: Percentage of Oncology Drugs Distributed Through Various Channels
Figure 72: Global Sterile Injectables Market Size and Share, By Region, 2017
Figure 73: Global Sterile Injectables Market Size and Share, By Region, 2023F
Figure 74: North America Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 75: Number of deaths due to cancer in North America
Figure 76: North America Population above 65 year in Million
Figure 77: North America Sterile Injectables Market Size, By Value, Forecast, 2018-2023(USD Billion )
Figure 78: North America Sterile Injectables Market: By Molecule Type, By Value, 2013-2023 (USD Billion)
Figure 79: North America Sterile Injectables Market: By Biologic Drug Type, By Value, 2013-2023 (USD Billion)
Figure 80: North America Sterile Injectables Market: By Indication, By Value, 2013-2023 (USD Billion)
Figure 81: North America Prevalence of Neurological Disorder (2012-2016, Million)
Figure 82: North America Prevalence of Neurological Disorder, By Type 2016
Figure 83: North America Prevelnace of Musculoskeletal Disorders (2012-2016, Million)
Figure 84: North America Prevalence of Gynecological Disorders (2012-2016)
Figure 85: Total Number of People with North America Neglected Tropical Disorders (2012-2016)
Figure 86: Total Number of People in North America with Different Type of Cardiovascular Disease in 2016
Figure 87: North America Sterile Injectables Market: By Distribution Channel, By Value, 2013-2023 (USD Billion)
Figure 88: North America Sterile Injectables Market, Country Share, 2017 (% of Total)
Figure 89: North America Sterile Injectables, Country Share, 2023 (% of Total)
Figure 90: United States Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 91: United States Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion)
Figure 92: U.S. Per Capita Health Expenditure, 2012-2016 ( USD)
Figure 93: U.S. Population Ages 65 and above, 2014 and Forecast (Million)
Figure 94: Per Capita Healthcare Expenditure in United States (2012-2016, USD)
Figure 95: U.S Health Spending by Type of Service or Product, 2016 (%)
Figure 96: United Sates Sterile Injectables Market: By Indication, By Value, 2013-2023 (USD Billion)
Figure 97: United States Prevalence of Cardiovascular Disorders, By Type in 2016
Figure 98: New Estimated Cases of Cancer in United States (2014-2018)
Figure 99: New Estimated Cases of Cancer in United States, By Gender 2018
Figure 100: New Estimated Cases of Cancer in United States, By Type 2018
Figure 101: United States Prevalence of Diabetes (Per 1,00,000 )2013-2016
Figure 102: United States Prevalence of Musculoskeletal Disorders (Per 1,00,000 )2013-2016
Figure 103: Prevalence of Neurological Disorders in United States (2016, Million)
Figure 104: United States Prevalence of Cardiovascular Disorders (Per 1,00,000 )2013-2016
Figure 105: Canada Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 106: Canada Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion)
Figure 107: Canada Per Capita Health Expenditure, 2012-2016 ( USD)
Figure 108: Canada Population Ages 65 and above, (% of Total,2012-2016)
Figure 109: Canada Sterile Injectables Market: By Indication, By Value, 2013-2023 (USD Billion)
Figure 110: Canada Prevalence of Diabetes (Per 1,00,000 )2013-2016
Figure 111: Canada Prevalence of Musculoskeletal Disorders (Per 1,00,000 )2013-2016
Figure 112: Canada Total Number of People With Sense Organ Disorders (2012-2016)
Figure 113: Canada Prevalence of Cardiovascular Disorders (Per 1,00,000 )2013-2016
Figure 114: Europe Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 115: Percentage of Male and Female deaths due to cancer in EU 28 2016
Figure 116: Europe Sterile Injectables Market Size, By Value, Forecast, 2018-2023(USD Billion )
Figure 117: Europe Sterile Injectables Market: By Molecule Type, By Value, 2013-2023 (USD Billion)
Figure 118: Europe Sterile Injectables Market: By Biologic Drug Type, By Value, 2013-2023 (USD Billion)
Figure 119: Europe Sterile Injectables Market: By Distribution Channel, By Value, 2013-2023 (USD Billion)
Figure 120: Europe Sterile Injectables Market: By Indication, By Value, 2013-2023 (USD Billion)
Figure 121: Western Europe Prevalence of Gynecological (2012-2016, Million)
Figure 122: Western Europe Prevalence of Musculoskeletal Disorders (2012-2016, Million)
Figure 123: Total Number of People With Cardiovascular Disorders in Western Europe, By Type,2016
Figure 124: Europe Sterile Injectables Market, Country Share, 2017 (% of Total)
Figure 125: Europe Sterile Injectables Market, Country Share, 2023 (% of Total)
Figure 126: Germany Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 127: Germany Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion)
Figure 128: Germany Sterile Injectables Market: By Indication, By Value, 2013-2023 (USD Billion)
Figure 129: Germany Prevalence of Musculoskeletal Disorders (Per 1,00,000 )2013-2016
Figure 130: United Kingdom Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 131: Germany Prevalence of Neurological Disorders (2012-2016, Million)
Figure 132: Germany Prevalence of Cardiovascular Disorders (Per 1,00,000 )2013-2016
Figure 133: United Kingdom Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 134: United Kingdom Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion)
Figure 135: United Kingdom Sterile Injectables Market: By Indication, By Value, 2013-2023 (USD Billion)
Figure 136: Estimated Number of People Living with cancer in United Kingdom
Figure 137: United Kingdom Prevalence of Diabetes Mellitus (Per 1,00,000 )2013-2016
Figure 138: United Kingdom Prevalence of Cardiovascular Disorders (Per 1,00,000 )2013-2016
Figure 139: United Kingdom Prevalence of Disorders (Per 1,00,000 )2013-2016
Figure 140: Rest of Europe Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 141: Rest of Europe Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion)
Figure 142: Asia Pacific Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 143: Ranking of countries from Asia-Pacific in the Global Access to Healthcare Index
Figure 144: Mobile health revenue forecast in Asia Pacific in 2017, by country (in billion U.S. dollars)
Figure 145: Asia Pacific Sterile Injectables Market Size, By Value, Forecast, 2018-2023(USD Billion )
Figure 146: Asia Pacific Sterile Injectables Market: By Molecule Type, By Value, 2013-2023 (USD Billion)
Figure 147: Asia Pacific Sterile Injectables Market: By Biologic Drug Type, By Value, 2013-2023 (USD Billion)
Figure 148: Asia Pacific Sterile Injectables Market: By Indication, By Value, 2013-2023 (USD Billion)
Figure 149: Prevalence of Neurological Disorders in South East Asia, East Asia and Oceania,2012-2016,Million
Figure 150: Prevalence of Musculoskeletal Disorders in South East Asia, East Asia and Oceania,(2012-2016, Million)
Figure 151: Total Number of People With Cardiovascular Disorders in South East Asia, East Asia and Oceania, By Type,2016
Figure 152: Asia Pacific Sterile Injectables Market: By Distribution Channel, By Value, 2013-2023 (USD Billion)
Figure 153: Asia Pacific Sterile Injectables Market, Country Share, 2017 (% of Total)
Figure 154: Asia Pacific Sterile Injectables, Country Share, 2023 (% of Total
Figure 155: China Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 156: China Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion)
Figure 157: China Healthcare Expenditure (2012-2016, USD Billion)
Figure 158: China Population 65 Years & Above (% of Total),2012-2016 )
Figure 159: China Sterile Injectables Market: By Indication, By Value, 2013-2023 (USD Billion)
Figure 160: China Prevalence of Diabetes Mellitus (Per 1,00,000 )2013-2016
Figure 161: China Prevalence of Disorders (Per 1,00,000 )2013-2016
Figure 162: China Prevalence of Cardiovascular Disorders (Per 1,00,000 )2013-2016
Figure 163: Japan Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 164: Japan Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion)
Figure 165: Japan Per Capita Health Expenditure (2012-2016,USD)
Figure 166: Japan Population 65 Years & Above (% of Total), 2012-2016
Figure 167: Japan Sterile Injectables Market: By Indication, By Value, 2013-2023 (USD Billion)
Figure 168: Japan Prevalence of Diabetes Mellitus (Per 1,00,000 )2013-2016
Figure 169: Japan Prevalence of Musculoskeletal Disorders (Per 1,00,000 )2013-2016
Figure 170: Japan Prevalence of Cardiovascular Disorders (Per 1,00,000 )2013-2016
Figure 171: India Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 172: India Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion)
Figure 173: India Sterile Injectables Market: By Indication, By Value, 2013-2023 (USD Billion)
Figure 174: India Prevalence of Diabetes Mellitus Per 1,00,000 )2013-2016
Figure 175: India Prevalence of Musculoskeletal Disorders (Per 1,00,000 )2013-2016
Figure 176: India Prevalence of Cardiovascular Disorders (Per 1,00,000) 2013-2016
Figure 177: Total Number of People With Infectious Disorder in India (2012-2016)
Figure 178: Rest of Asia Pacific Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 179: Rest of Asia Pacific Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion)
Figure 180: Rest of World Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 181: Rest of World Sterile Injectables Market Size, By Value, Forecast, 2018-2023(USD Billion )
Figure 182: Rest of World Sterile Injectables Market: By Molecule Type, By Value, 2013-2023 (USD Billion)
Figure 183: Rest of World Sterile Injectables Market: By Indication, By Value, 2013-2023 (USD Billion)
Figure 184: Prevalence of Infectious Disorder in Middle East and North Africa Region (2012-2016, Million)
Figure 185: Prevalence of Infectious Disorder in Middle East and North Africa Region (2012-2016, Million)
Figure 186: Prevalence of Sense Organ Disorders in Middle East and North Africa Region (2012-2016, Million)
Figure 187: Rest of World Sterile Injectables Market: By Biologic Drug Type, By Value, 2013-2023 (USD Billion)
Figure 188: Rest of World Sterile Injectables Market: By Distribution Channel, By Value, 2013-2023 (USD Billion)
Figure 189: Rest of World Sterile Injectables Market, Country Share, 2017 (% of Total)
Figure 190: Rest of World Sterile Injectables, Country Share, 2023 (% of Total)
Figure 191: Brazil Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 192: Brazil Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion)
Figure 193: Brazil Sterile Injectables Market: By Indication, By Value, 2013-2023 (USD Billion)
Figure 194: Brazil Prevalence of Diabetes (Per 1,00,000 )2013-2016
Figure 195: Brazil Prevalence of Disorders (Per 1,00,000 )2013-2016
Figure 196: Brazil Prevalence of Cardiovascular Disorders (Per 1,00,000 )2013-2016
Figure 197: Total Number of People With Infectious Disorder in Brazil (2012-2016)
Figure 198: Saudi Arabia Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 199: Saudi Arabia Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion)
Figure 200: Saudi Arabia Sterile Injectables Market: By Indication, By Value, 2013-2023 (USD Billion)
Figure 201: Saudi Arabia Prevalence of Cardiovascular Disorders (Per 1,00,000 )2013-2016
Figure 202: Saudi Arabia Prevalence of Diabetes (Per 1,00,000 )2013-2016
Figure 203: Saudi Arabia Prevalence of Disorders (Per 1,00,000 )2013-2016
Figure 204: Total Number of People With Infectious Disorder in Saudi Arabia (2012-2016)
Figure 205: Others Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 206: Others Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion)
Figure 207: Pfizer, Revenue, 2015-2017 (USD Millions)
Figure 208: Pfizer Segmental Breakup, 2017 (%)
Figure 209: Pfizer Sales, By Country, 2017 (%)
Figure 210: Baxter International, Revenues, 2014-2016 (USD Billion)
Figure 211: Baxter International, Net Sales, By Segment, 2016 (%)
Figure 212: Baxter International, Net Sales, By Region, 2016 (%)
Figure 213: Novartis, Sales, 2013-2017 (USD Millions)
Figure 214: Novartis Sales, By Segment 2017 (%)
Figure 215: Novartis Sales, By Geography,2017 (%)
Figure 216: Gilead Sciences Product Sales, 2016 (%)
Figure 217: Gilead Sciences HCV Product Sales, 2014-2016 (USD Billion)
Figure 218: Net Sales, By Geographic Location, % Share 2016
Figure 219: Net Revenue, By Business Segment, % Share 2017
Figure 220: Net Sales, 2014-2017 (In million USD)
Figure 1: Sterile Injectables Market By Type
Figure 2: Global Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 3: Global Sterile Injectables Market Size, By Value, Forecast, 2018-2023 (USD Billion)
Figure 4: Global Health Expenditure Per Capita,(2012-2016, USD Trillion)
Figure 5: Global Health Expenditure Per Capita, By Select Countries,(2016, USD)
Figure 6: Global Population Aged 65 and Above, 2012-2015 (% of Total)
Figure 7: Global Diabetic Population, By Region, 2015 (Billion)
Figure 8: Global Sterile Injectables Market Size, By Molecule Type, 2017 (%)
Figure 9: Global Sterile Injectables Market Size, By Molecule Type, 2023F (%)
Figure 10: Global Biologic Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 11: Global Biologic Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion)
Figure 12: Global Small Molecule Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 13: Global Small Molecule Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion)
Figure 14: Global Sterile Injectables Market Size, By Type, 2017 (%)
Figure 15: Global Therapeutic and Monitoring Devices Market Size, By Type, 2023F (%)
Figure 16: Global Monoclonal Antibody Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 17: Global Monoclonal Antibody Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion)
Figure 18: Global Insulin Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 19: Global Insulin Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion)
Figure 20: Top 10 Leading countries with diabetes Prevalence, Million, 2017
Figure 21: Highest Revenue Generating Insulin Drugs in 2016 & 2017
Figure 22: Global Vaccines Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 23: Global Vaccines Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion)
Figure 24: Market Share of Leading Vaccines Manufacturers
Figure 25: Global Vaccine Doses Consumption, By Income Group (Million,2016)
Figure 26: Global Fusion Proteins Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 27: Global Fusion Proteins Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion)
Figure 28: Global Immunoglobulins Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 29: Global Immunoglobulins Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion)
Figure 30: Global Others Biologic Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 31: Global Others Biologic Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion)
Figure 32: Global Sterile Injectables Market Size, By Indication, 2017 (%)
Figure 33: Global Sterile Injectables Market Size, By Indication, 2023F (%)
Figure 34: Global Sterile Injectables For Oncological Disorders Market Size, By Value, 2013-2017 (USD Billion)
Figure 35: Global Sterile Injectables For Oncological Disorders Market Size, By Value 2018E-2023F (USD Billion)
Figure 36: Number of People With Cancer, By Type, 2016 (Million)
Figure 37: Global Sterile Injectables For Infectious Disorders Market Size, By Value, 2013-2017 (USD Billion)
Figure 38: Global Sterile Injectables For Infectious Disorders Market Size, By Value 2018E-2023F (USD Billion)
Figure 39: Global Prevalence of Different Type of Infectious Disorders (2016,%)
Figure 40: Global Prevalence of Infectious Disorders (2012-2016, Million)
Figure 41: Global Prevalence of Neglected Tropical Disorders in (2012-2016, Million)
Figure 42: Global Prevalence of Neglected Tropical Disorders, By Type (2016,%)
Figure 43: Global Sterile Injectables For Metabolic Disorders Market Size, By Value, 2013-2017 (USD Billion)
Figure 44: Global Sterile Injectables For Metabolic Disorders Market Size, By Value 2018E-2023F (USD Billion)
Figure 45: Global Diabetes Prevalence (2017&2045, Million)
Figure 46: Global Sterile Injectables For Cardiovascular Disorders Market Size, By Value, 2013-2017 (USD Billion)
Figure 47: Global Sterile Injectables For Cardiovascular Disorders Size, By Value 2018E-2023F (USD Billion)
Figure 48: Cardiovascular Disease Prevelance, By Type,2016
Figure 49: Global Prevalence of Cardiovascular Disease (2012-2016, Million)
Figure 50: Global Sterile Injectables For Neurological Disorders Market Size, By Value, 2013-2017 (USD Billion)
Figure 51: Global Sterile Injectables For Neurological Disorders Market Size, By Value 2018E-2023F (USD Billion)
Figure 52: Neurological Disorders Prevalence, By Type,2016
Figure 53: Global Prevalence of Neurological Disorders (2012-2016, Billion)
Figure 54: Global Sterile Injectables For Musculoskeletal Disorders Market Size, By Value, 2013-2017 (USD Billion)
Figure 55: Global Sterile Injectables For Musculoskeletal Disorders Market Size, By Value 2018E-23F (USD Billion)
Figure 56: Musculoskeletal Disorders Prevalence, By Type, 2016
Figure 57: Global Prevalence of Musculoskeletal Disorders (2012-2016, Billion)
Figure 58: Global Others Indication Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 59: Global Others Indication Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion)
Figure 60: Global Prevalence of Gynecological Disorder (2012-2016, Million)
Figure 61: Global Prevalence of Gynecological Disorder, By Type 2016
Figure 62: Global Prevalence of Sense Organ Disorder (2012-2016, Million)
Figure 63: Global Sterile Injectables Market Size, By Distribution Channel, 2017 (%)
Figure 64: Global Sterile Injectables Market Size, By Distribution Channel, 2023F (%)
Figure 65: Global Hospital Pharmacy Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 66: Global Hospital Pharmacy Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion)
Figure 67: Global Retail Pharmacy Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 68: Global Retail Pharmacy Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion)
Figure 69: Global Ecommerce Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 70: Global Ecommerce Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion)
Figure 71: Percentage of Oncology Drugs Distributed Through Various Channels
Figure 72: Global Sterile Injectables Market Size and Share, By Region, 2017
Figure 73: Global Sterile Injectables Market Size and Share, By Region, 2023F
Figure 74: North America Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 75: Number of deaths due to cancer in North America
Figure 76: North America Population above 65 year in Million
Figure 77: North America Sterile Injectables Market Size, By Value, Forecast, 2018-2023(USD Billion )
Figure 78: North America Sterile Injectables Market: By Molecule Type, By Value, 2013-2023 (USD Billion)
Figure 79: North America Sterile Injectables Market: By Biologic Drug Type, By Value, 2013-2023 (USD Billion)
Figure 80: North America Sterile Injectables Market: By Indication, By Value, 2013-2023 (USD Billion)
Figure 81: North America Prevalence of Neurological Disorder (2012-2016, Million)
Figure 82: North America Prevalence of Neurological Disorder, By Type 2016
Figure 83: North America Prevelnace of Musculoskeletal Disorders (2012-2016, Million)
Figure 84: North America Prevalence of Gynecological Disorders (2012-2016)
Figure 85: Total Number of People with North America Neglected Tropical Disorders (2012-2016)
Figure 86: Total Number of People in North America with Different Type of Cardiovascular Disease in 2016
Figure 87: North America Sterile Injectables Market: By Distribution Channel, By Value, 2013-2023 (USD Billion)
Figure 88: North America Sterile Injectables Market, Country Share, 2017 (% of Total)
Figure 89: North America Sterile Injectables, Country Share, 2023 (% of Total)
Figure 90: United States Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 91: United States Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion)
Figure 92: U.S. Per Capita Health Expenditure, 2012-2016 ( USD)
Figure 93: U.S. Population Ages 65 and above, 2014 and Forecast (Million)
Figure 94: Per Capita Healthcare Expenditure in United States (2012-2016, USD)
Figure 95: U.S Health Spending by Type of Service or Product, 2016 (%)
Figure 96: United Sates Sterile Injectables Market: By Indication, By Value, 2013-2023 (USD Billion)
Figure 97: United States Prevalence of Cardiovascular Disorders, By Type in 2016
Figure 98: New Estimated Cases of Cancer in United States (2014-2018)
Figure 99: New Estimated Cases of Cancer in United States, By Gender 2018
Figure 100: New Estimated Cases of Cancer in United States, By Type 2018
Figure 101: United States Prevalence of Diabetes (Per 1,00,000 )2013-2016
Figure 102: United States Prevalence of Musculoskeletal Disorders (Per 1,00,000 )2013-2016
Figure 103: Prevalence of Neurological Disorders in United States (2016, Million)
Figure 104: United States Prevalence of Cardiovascular Disorders (Per 1,00,000 )2013-2016
Figure 105: Canada Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 106: Canada Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion)
Figure 107: Canada Per Capita Health Expenditure, 2012-2016 ( USD)
Figure 108: Canada Population Ages 65 and above, (% of Total,2012-2016)
Figure 109: Canada Sterile Injectables Market: By Indication, By Value, 2013-2023 (USD Billion)
Figure 110: Canada Prevalence of Diabetes (Per 1,00,000 )2013-2016
Figure 111: Canada Prevalence of Musculoskeletal Disorders (Per 1,00,000 )2013-2016
Figure 112: Canada Total Number of People With Sense Organ Disorders (2012-2016)
Figure 113: Canada Prevalence of Cardiovascular Disorders (Per 1,00,000 )2013-2016
Figure 114: Europe Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 115: Percentage of Male and Female deaths due to cancer in EU 28 2016
Figure 116: Europe Sterile Injectables Market Size, By Value, Forecast, 2018-2023(USD Billion )
Figure 117: Europe Sterile Injectables Market: By Molecule Type, By Value, 2013-2023 (USD Billion)
Figure 118: Europe Sterile Injectables Market: By Biologic Drug Type, By Value, 2013-2023 (USD Billion)
Figure 119: Europe Sterile Injectables Market: By Distribution Channel, By Value, 2013-2023 (USD Billion)
Figure 120: Europe Sterile Injectables Market: By Indication, By Value, 2013-2023 (USD Billion)
Figure 121: Western Europe Prevalence of Gynecological (2012-2016, Million)
Figure 122: Western Europe Prevalence of Musculoskeletal Disorders (2012-2016, Million)
Figure 123: Total Number of People With Cardiovascular Disorders in Western Europe, By Type,2016
Figure 124: Europe Sterile Injectables Market, Country Share, 2017 (% of Total)
Figure 125: Europe Sterile Injectables Market, Country Share, 2023 (% of Total)
Figure 126: Germany Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 127: Germany Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion)
Figure 128: Germany Sterile Injectables Market: By Indication, By Value, 2013-2023 (USD Billion)
Figure 129: Germany Prevalence of Musculoskeletal Disorders (Per 1,00,000 )2013-2016
Figure 130: United Kingdom Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 131: Germany Prevalence of Neurological Disorders (2012-2016, Million)
Figure 132: Germany Prevalence of Cardiovascular Disorders (Per 1,00,000 )2013-2016
Figure 133: United Kingdom Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 134: United Kingdom Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion)
Figure 135: United Kingdom Sterile Injectables Market: By Indication, By Value, 2013-2023 (USD Billion)
Figure 136: Estimated Number of People Living with cancer in United Kingdom
Figure 137: United Kingdom Prevalence of Diabetes Mellitus (Per 1,00,000 )2013-2016
Figure 138: United Kingdom Prevalence of Cardiovascular Disorders (Per 1,00,000 )2013-2016
Figure 139: United Kingdom Prevalence of Disorders (Per 1,00,000 )2013-2016
Figure 140: Rest of Europe Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 141: Rest of Europe Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion)
Figure 142: Asia Pacific Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 143: Ranking of countries from Asia-Pacific in the Global Access to Healthcare Index
Figure 144: Mobile health revenue forecast in Asia Pacific in 2017, by country (in billion U.S. dollars)
Figure 145: Asia Pacific Sterile Injectables Market Size, By Value, Forecast, 2018-2023(USD Billion )
Figure 146: Asia Pacific Sterile Injectables Market: By Molecule Type, By Value, 2013-2023 (USD Billion)
Figure 147: Asia Pacific Sterile Injectables Market: By Biologic Drug Type, By Value, 2013-2023 (USD Billion)
Figure 148: Asia Pacific Sterile Injectables Market: By Indication, By Value, 2013-2023 (USD Billion)
Figure 149: Prevalence of Neurological Disorders in South East Asia, East Asia and Oceania,2012-2016,Million
Figure 150: Prevalence of Musculoskeletal Disorders in South East Asia, East Asia and Oceania,(2012-2016, Million)
Figure 151: Total Number of People With Cardiovascular Disorders in South East Asia, East Asia and Oceania, By Type,2016
Figure 152: Asia Pacific Sterile Injectables Market: By Distribution Channel, By Value, 2013-2023 (USD Billion)
Figure 153: Asia Pacific Sterile Injectables Market, Country Share, 2017 (% of Total)
Figure 154: Asia Pacific Sterile Injectables, Country Share, 2023 (% of Total
Figure 155: China Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 156: China Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion)
Figure 157: China Healthcare Expenditure (2012-2016, USD Billion)
Figure 158: China Population 65 Years & Above (% of Total),2012-2016 )
Figure 159: China Sterile Injectables Market: By Indication, By Value, 2013-2023 (USD Billion)
Figure 160: China Prevalence of Diabetes Mellitus (Per 1,00,000 )2013-2016
Figure 161: China Prevalence of Disorders (Per 1,00,000 )2013-2016
Figure 162: China Prevalence of Cardiovascular Disorders (Per 1,00,000 )2013-2016
Figure 163: Japan Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 164: Japan Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion)
Figure 165: Japan Per Capita Health Expenditure (2012-2016,USD)
Figure 166: Japan Population 65 Years & Above (% of Total), 2012-2016
Figure 167: Japan Sterile Injectables Market: By Indication, By Value, 2013-2023 (USD Billion)
Figure 168: Japan Prevalence of Diabetes Mellitus (Per 1,00,000 )2013-2016
Figure 169: Japan Prevalence of Musculoskeletal Disorders (Per 1,00,000 )2013-2016
Figure 170: Japan Prevalence of Cardiovascular Disorders (Per 1,00,000 )2013-2016
Figure 171: India Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 172: India Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion)
Figure 173: India Sterile Injectables Market: By Indication, By Value, 2013-2023 (USD Billion)
Figure 174: India Prevalence of Diabetes Mellitus Per 1,00,000 )2013-2016
Figure 175: India Prevalence of Musculoskeletal Disorders (Per 1,00,000 )2013-2016
Figure 176: India Prevalence of Cardiovascular Disorders (Per 1,00,000) 2013-2016
Figure 177: Total Number of People With Infectious Disorder in India (2012-2016)
Figure 178: Rest of Asia Pacific Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 179: Rest of Asia Pacific Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion)
Figure 180: Rest of World Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 181: Rest of World Sterile Injectables Market Size, By Value, Forecast, 2018-2023(USD Billion )
Figure 182: Rest of World Sterile Injectables Market: By Molecule Type, By Value, 2013-2023 (USD Billion)
Figure 183: Rest of World Sterile Injectables Market: By Indication, By Value, 2013-2023 (USD Billion)
Figure 184: Prevalence of Infectious Disorder in Middle East and North Africa Region (2012-2016, Million)
Figure 185: Prevalence of Infectious Disorder in Middle East and North Africa Region (2012-2016, Million)
Figure 186: Prevalence of Sense Organ Disorders in Middle East and North Africa Region (2012-2016, Million)
Figure 187: Rest of World Sterile Injectables Market: By Biologic Drug Type, By Value, 2013-2023 (USD Billion)
Figure 188: Rest of World Sterile Injectables Market: By Distribution Channel, By Value, 2013-2023 (USD Billion)
Figure 189: Rest of World Sterile Injectables Market, Country Share, 2017 (% of Total)
Figure 190: Rest of World Sterile Injectables, Country Share, 2023 (% of Total)
Figure 191: Brazil Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 192: Brazil Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion)
Figure 193: Brazil Sterile Injectables Market: By Indication, By Value, 2013-2023 (USD Billion)
Figure 194: Brazil Prevalence of Diabetes (Per 1,00,000 )2013-2016
Figure 195: Brazil Prevalence of Disorders (Per 1,00,000 )2013-2016
Figure 196: Brazil Prevalence of Cardiovascular Disorders (Per 1,00,000 )2013-2016
Figure 197: Total Number of People With Infectious Disorder in Brazil (2012-2016)
Figure 198: Saudi Arabia Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 199: Saudi Arabia Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion)
Figure 200: Saudi Arabia Sterile Injectables Market: By Indication, By Value, 2013-2023 (USD Billion)
Figure 201: Saudi Arabia Prevalence of Cardiovascular Disorders (Per 1,00,000 )2013-2016
Figure 202: Saudi Arabia Prevalence of Diabetes (Per 1,00,000 )2013-2016
Figure 203: Saudi Arabia Prevalence of Disorders (Per 1,00,000 )2013-2016
Figure 204: Total Number of People With Infectious Disorder in Saudi Arabia (2012-2016)
Figure 205: Others Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Figure 206: Others Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion)
Figure 207: Pfizer, Revenue, 2015-2017 (USD Millions)
Figure 208: Pfizer Segmental Breakup, 2017 (%)
Figure 209: Pfizer Sales, By Country, 2017 (%)
Figure 210: Baxter International, Revenues, 2014-2016 (USD Billion)
Figure 211: Baxter International, Net Sales, By Segment, 2016 (%)
Figure 212: Baxter International, Net Sales, By Region, 2016 (%)
Figure 213: Novartis, Sales, 2013-2017 (USD Millions)
Figure 214: Novartis Sales, By Segment 2017 (%)
Figure 215: Novartis Sales, By Geography,2017 (%)
Figure 216: Gilead Sciences Product Sales, 2016 (%)
Figure 217: Gilead Sciences HCV Product Sales, 2014-2016 (USD Billion)
Figure 218: Net Sales, By Geographic Location, % Share 2016
Figure 219: Net Revenue, By Business Segment, % Share 2017
Figure 220: Net Sales, 2014-2017 (In million USD)
LIST OF TABLES
Table A: Recent Mergers and Collaborations in Sterile Injectables Industry
Table B: List of Some Monoclonal Antibody Drugs Available in Market
Table C: Antibody therapeutics in late-stage clinical studies for non-cancer indications.
Table D: Antibody therapeutics in late-stage clinical studies for non-cancer indications.
Table E: Antibody therapeutics in late-stage clinical studies for Cancer Indications.
Table F: Antibody therapeutics in late-stage clinical studies for Cancer Indications
Table G: List of Some Insulin Sterile Injectables Drugs Available in Market
Table H: List of Some Insulin Sterile Injectables Drugs Available in Market
Table I: List of Insulin Manufacturers, in Selected Countries
Table J: GlaxoSmithKline Vaccine Pipeline
Table K: Pfizer Vaccine Pipeline
Table A: Recent Mergers and Collaborations in Sterile Injectables Industry
Table B: List of Some Monoclonal Antibody Drugs Available in Market
Table C: Antibody therapeutics in late-stage clinical studies for non-cancer indications.
Table D: Antibody therapeutics in late-stage clinical studies for non-cancer indications.
Table E: Antibody therapeutics in late-stage clinical studies for Cancer Indications.
Table F: Antibody therapeutics in late-stage clinical studies for Cancer Indications
Table G: List of Some Insulin Sterile Injectables Drugs Available in Market
Table H: List of Some Insulin Sterile Injectables Drugs Available in Market
Table I: List of Insulin Manufacturers, in Selected Countries
Table J: GlaxoSmithKline Vaccine Pipeline
Table K: Pfizer Vaccine Pipeline
